Created at 3:02 a.m. Sep, 17, 2025
Author: mustafa
Related Note: 1506457768755 1
Rationale for change

This card is TOTALLY WRONG.

Supportive care is the mainstay of treatment for respiratory syncytial virus (RSV) infection in adults. There are currently no routinely recommended RSV-specific antivirals for immunocompetent adults.

This is mentioned explicitly at a 2024 recent Lancet review: Wildenbeest, J. G., et al. "Respiratory Syncytial Virus Infections in Adults: A Narrative Review." The Lancet Respiratory Medicine, vol. 12, no. 10, 2024, pp. 822–836. https://doi.org/10.1016/S2213-2600(24)00255-8

Regarding Ribavirin: It's rarely used and generally reserved for severely immunocompromised patients (already mentioned in sketchy) with life-threatening disease, but its efficacy in adults remains controversial and is not standard of care.

This is mentioned in The American Society of Transplantation guidlines (2019): Manuel, Oriol, and Meredith Estabrook. “RNA Respiratory Viral Infections in Solid Organ Transplant Recipients: Guidelines From the American Society of Transplantation Infectious Diseases Communi
Source: Society Guidelines - https://pubmed.ncbi.nlm.nih.gov/39265602/

Text Text
Sketchy Extra Sketchy Extra
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::03_Microbiology::05_Virology::15_Paramyxoviruses #AK_Step1_v12::#FirstAid::03_Microbiology::05_Virology::09_RNA_viruses #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::08_Retired_Lessons::04_Ribavirin,_Sofosbuvir,_Simeprevir_[Retired_Video] #AK_Step1_v12::^Systems::GI::pharm #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::02_Other_applications::*Ribavirin #AK_Other::Only_Step_1 #AK_Step1_v12::#SketchyMicro::03_Viruses::02_RNA_(-)_Sense::03_Respiratory_Syncytial_Virus_&_Human_Metapneumovirus_(Pneumoviridae) #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#SketchyMicro::03_Viruses::04_Retired_Lessons::09_Measles_virus,_mumps_virus,_respiratory_syncytial_virus,_parainfluenza_virus_(Paramyxoviridae)_[Retired_Video] #AK_Step1_v12::#B&B::20_Pulm::03_Other_Pulmonary_Topics::02_Pneumonia_II::Extra #AK_Step1_v12::#Physeo::06_Micro::05_Viruses::30_Respiratory_Syncytial_Virus_(RSV)_&_Human_Metapneumovirus_(hPMV) #AK_Step1_v12::#Pixorize::04_Microbiology::08_Viruses-RNA_Viruses::24_Respiratory_Syncytial_Virus_(RSV) #AK_Step1_v12::#Bootcamp::Microbiology::29_Negative-sense_RNA_Viruses::05_Respiratory_Syncytial_Virus #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Infectious_Disease::Pneumonia #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::51_Hepatitis_C_therapy #AK_Step1_v12::#UWorld::COMLEX::24779 #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::*Palivizumab #AK_Step1_v12::#UWorld::Step::1668